Source:http://linkedlifedata.com/resource/pubmed/id/10717911
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
2000-5-10
|
pubmed:abstractText |
The aim of this study was to evaluate the roles of 67Ga-citrate and 99Tcm-methylene diphosphonate (99Tcm-MDP) planar and single photon emission tomographic (SPET) imaging in patients with vertebral osteomyelitis. Thirty patients (22 females, 8 males) aged 62.7 +/- 16.4 years (mean +/- s) were enrolled prospectively between May 1995 and May 1998. The patients had been on antibiotics for 7 +/- 4 weeks prior to the study. Histology was available for all but nine patients with mild infections, who were evaluated by a combination of magnetic resonance imaging (MRI), clinical and laboratory tests. 67Ga-citrate (185 MBq) and three-phase bone (555 MBq 99Tcm-MDP) planar and SPET imaging were performed in all patients, together with MRI as a comparison. In total, 67 infectious foci were detected. Based on histology, there were four cases of severe, 13 cases of moderate and four cases of mild osteomyelitis; nine mild infections were also classified by the combination of MRI, clinical and laboratory results. Combined MRI and 67Ga-citrate SPET correctly classified all patients; MRI detected all 67 infectious foci, whereas 67Ga-citrate SPET identified 54 only. False-negative results were seen with all other modalities, especially in cases of mild and moderate infection. 67Ga-citrate SPET identified unsuspected cases of endocarditis (n = 2), paravertebral abscess (n = 1), subaxillary soft tissue abscess (n = 1) and rib osteomyelitis (n = 1). For 67Ga-citrate SPET, the target-to-background ratio was 2.24 +/- 0.31, 1.76 +/- 0.07 and 1.30 +/- 0.18 for severe, moderate and mild osteomyelitis, respectively. Significant differences were noted between severe and moderate infection (P = 0.0051) and between severe and mild infection (P < 0.0001); that between moderate and mild infection was non-significant. For 99Tcm-MDP planar and SPET imaging, and for planar 67Ga-citrate imaging, there was no correlation with severity. We conclude that 67Ga-citrate SPET is able to identify vertebral osteomyelitis and detect additional sites of infection. It can also aid in determining the severity of infection and, potentially, the response to therapy.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/C-Reactive Protein,
http://linkedlifedata.com/resource/pubmed/chemical/Citrates,
http://linkedlifedata.com/resource/pubmed/chemical/Gallium,
http://linkedlifedata.com/resource/pubmed/chemical/Gallium Radioisotopes,
http://linkedlifedata.com/resource/pubmed/chemical/Radiopharmaceuticals,
http://linkedlifedata.com/resource/pubmed/chemical/Technetium Tc 99m Medronate,
http://linkedlifedata.com/resource/pubmed/chemical/gallium citrate
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jan
|
pubmed:issn |
0143-3636
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
21
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
111-20
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:10717911-Aged,
pubmed-meshheading:10717911-Blood Sedimentation,
pubmed-meshheading:10717911-C-Reactive Protein,
pubmed-meshheading:10717911-Citrates,
pubmed-meshheading:10717911-Female,
pubmed-meshheading:10717911-Gallium,
pubmed-meshheading:10717911-Gallium Radioisotopes,
pubmed-meshheading:10717911-Humans,
pubmed-meshheading:10717911-Leukocyte Count,
pubmed-meshheading:10717911-Magnetic Resonance Imaging,
pubmed-meshheading:10717911-Male,
pubmed-meshheading:10717911-Osteomyelitis,
pubmed-meshheading:10717911-Radiopharmaceuticals,
pubmed-meshheading:10717911-Spine,
pubmed-meshheading:10717911-Technetium Tc 99m Medronate
|
pubmed:year |
2000
|
pubmed:articleTitle |
67Ga-citrate and 99Tcm-MDP for estimating the severity of vertebral osteomyelitis.
|
pubmed:affiliation |
Department of Nuclear Medicine, Georg-August-University, Göttingen, Germany. sgratz@med.uni-goettingen.de
|
pubmed:publicationType |
Journal Article,
Clinical Trial
|